GalenicaGALNF 79 ROC (Joel Greenblatt) % is 41.28% as of Dec. 2025, which is 15% above its 10-year median of 36.00. GuruFocus rates GALNF with a GF Score™ of 79/100 and a GF Value™ of $114.47. The stock has 1 warning sign investors should review. Among 118 Medical Distribution companies, Galenica ranks better than 79.66% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Galenica's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 41.28%.
The historical rank and industry rank for Galenica's ROC (Joel Greenblatt) % or its related term are showing as below:
GALNF'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 25.78 Med: 36 Max: 41.28
Current: 38.83
During the past 13 years, Galenica's highest ROC (Joel Greenblatt) % was 41.28%. The lowest was 25.78%. And the median was 36.00%.
GALNF's ROC (Joel Greenblatt) % is ranked better than 79.66% of 118
companies
in the Medical Distribution industry
Industry Median: 15.345
vs GALNF: 38.83
Galenica's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 4.70% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
The historical data trend for Galenica's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GALNF vs MCK, CAH, COR: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Galenica's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galenica ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Galenica's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Galenica's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 41.28% mean?
Galenica (GALNF) has a ROC (Joel Greenblatt) % of 41.28% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Galenica and its competitors. This is 15% above median its historical median of 36.00. Over the past decade, Galenica's ROC (Joel Greenblatt) % has ranged from 25.78 to 41.28. According to the industry distribution chart, Galenica ranks #24 out of 118 companies in the Medical Distribution industry, placing it in the top 20.3%.
Is Galenica's ROC (Joel Greenblatt) % too high?
Galenica's current ROC (Joel Greenblatt) % of 41.28% is 15% above median its 10-year median of 36.00. Over the past 10 years, this metric has ranged from a low of 25.78 to a high of 41.28. The Medical Distribution industry median ROC (Joel Greenblatt) % is 15.35. Galenica's value of 41.28% is 169% above this industry median. Based on the distribution chart, Galenica ranks #24 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Galenica has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Galenica's ROC (Joel Greenblatt) % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Galenica ranks #24 out of 118 companies for ROC (Joel Greenblatt) %. This places Galenica in the top 20% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 15.35. Galenica's value of 41.28% is 169% above this benchmark. Historically, Galenica's own ROC (Joel Greenblatt) % has ranged from 25.78 to 41.28 over the past decade. While the company's 10-year median is 36.00 vs. the industry median of 15.35, Galenica has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 15.35, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galenica's current ROC (Joel Greenblatt) % of 41.28% is 169% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Galenica and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 15.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galenica's current ROC (Joel Greenblatt) % is 41.28%, which is 15% above median its own 10-year median of 36.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galenica stock overvalued right now?
Galenica (GALNF) has a current ROC (Joel Greenblatt) % of 41.28%. The stock's GF Value™ is $114.47, compared to a current price of $115.00 — trading 0.5% above its estimated fair value. The current ROC (Joel Greenblatt) % is 41.28%, which is 15% above median its 10-year median of 36.00 and 169% above the Medical Distribution industry median of 15.35. Galenica's overall GF Score™ is 79/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Galenica (GALNF), the current ROC (Joel Greenblatt) % is 41.28% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Galenica (GALNF) Overvalued in 2026?
Based on GuruFocus' analysis, Galenica stock appears to be overvalued.
The current stock price of $115.00 is trading 0.5% above its estimated GF Value™ of $114.47.
Key valuation signals for GALNF:
ROC (Joel Greenblatt) %: 41.28% (15% above median its 10-year median of 36.00)
GF Value™: $114.47 vs. price of $115.00 (0.5% above fair value)
Industry Position: 169% above the Medical Distribution median (#24 of 118)
No single metric tells the full story. See the GALNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
79GF Score
Get the complete analysis for GALNF
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GALNF has been successfully added to your 
